Racial and ethnic inequities in substance use treatment among women with opioid use disorder

References

• Centers for Disease Control and Prevention. CDC Wonder. 2021. https://wonder.cdc.gov/.
   Google Scholar
• Springer SA, Biondi BE, Frank C, El-Bassel N. A call to action to combat the opioid epidemic among women. J Addict Med. 2020;14:364–6. doi:10.1097/ADM.0000000000000622.
   PubMed Web of Science ®Google Scholar
• Han B, Compton WM, Blanco C, Jones CM. Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults. J Clin Psychiatry. 2018;79. doi:10.4088/JCP.17m11973.
   Web of Science ®Google Scholar
• Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011;37:313–23. doi:10.3109/00952990.2011.596982.
   PubMed Web of Science ®Google Scholar
• VanHouten JP, Rudd RA, Ballesteros MF, Mack KA. Drug overdose deaths among women aged 30-64 years - United States, 1999–2017. MMWR Morb Mortal Wkly Rep. 2019;68:1–5. doi:10.15585/mmwr.mm6801a1.
   PubMed Web of Science ®Google Scholar
• Hansen H, Netherland J. Is the prescription opioid epidemic a white problem? Am J Public Health. 2016;106:2127–29. doi:10.2105/AJPH.2016.303483.
   PubMed Web of Science ®Google Scholar
• AHRQ. Blacks experiencing fast-rising rates of overdose deaths involving synthetic opioids other than methadone 2020. https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/dataspotlight-opioid.pdf.
   Google Scholar
• Barbosa-Leiker C, Campbell ANC, McHugh RK, Guille C, Greenfield SF. Opioid use disorder in women and the implications for treatment. Psychiatr Res Clin Pract. 2021;3:3–11. doi:10.1176/appi.prcp.20190051.
   PubMedGoogle Scholar
• D’Orsogna MR, Bottcher L, Chou T. Acceleration of regional, racial and gender disparities in drug overdoses across the United States driven by COVID-19 and fentanyl use. MedRxiv: The PrePrint Server for Health Sciences. 2022.
   Google Scholar
• Kolodny A, Frieden TR. Ten Steps the federal government should take now to reverse the opioid addiction epidemic. JAMA. 2017;318:1537–8. doi:10.1001/jama.2017.14567.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerda M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: a yearly assessment from 2010 to 2019. J Drug Policy. 2022;110:103786.
   PubMedGoogle Scholar
• Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1–21. doi:10.1016/j.drugalcdep.2006.05.012.
   PubMed Web of Science ®Google Scholar
• Martin CE, Scialli A, Terplan M. Unmet substance use disorder treatment need among reproductive age women. Drug Alcohol Depend. 2020;206:107679. doi:10.1016/j.drugalcdep.2019.107679.
   PubMed Web of Science ®Google Scholar
• Martin CE, Parlier-Ahmad AB, Beck L, Scialli A, Terplan M. Need for and receipt of substance use disorder treatment among adults, by gender, in the United States. Public Health Rep. 2022;137:955–63. doi:10.1177/00333549211041554.
   PubMed Web of Science ®Google Scholar
• Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33:339–55. doi:10.1016/j.psc.2010.01.004.
   PubMed Web of Science ®Google Scholar
• Mulvaney-Day N, DeAngelo D, Chen CN, Cook BL, Alegria M. Unmet need for treatment for substance use disorders across race and ethnicity. Drug Alcohol Depend. 2012;125:S44–50. doi:10.1016/j.drugalcdep.2012.05.005.
   PubMed Web of Science ®Google Scholar
• Saini J, Johnson B, DM Q. Self-reported treatment need and barriers to care for adults with opioid use disorder: the US national survey on drug use and Health, 2015 to 2019. Am J Public Health. 2022;112:284–95. doi:10.2105/AJPH.2021.306577.
   PubMed Web of Science ®Google Scholar
• Perron BE, Mowbray OP, Glass JE, Delva J, Vaughn MG, Howard MO. Differences in service utilization and barriers among blacks, hispanics, and whites with drug use disorders. Subst Abuse Treat Prev Policy. 2009;4:3. doi:10.1186/1747-597X-4-3.
   PubMed Web of Science ®Google Scholar
• Krawczyk N, Feder KA, Fingerhood MI, Saloner B. Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug Alcohol Depend. 2017;178:512–8. doi:10.1016/j.drugalcdep.2017.06.009.
   PubMed Web of Science ®Google Scholar
• Saloner B, Le Cook B. Blacks and hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff (Millwood). 2013;32:135–45. doi:10.1377/hlthaff.2011.0983.
   PubMed Web of Science ®Google Scholar
• Andraka-Christou B. Addressing racial and ethnic disparities in the use of medications for opioid use disorder. Health Aff (Millwood). 2021;40:920–7. doi:10.1377/hlthaff.2020.02261.
   PubMed Web of Science ®Google Scholar
• Mereish EH, Bradford JB. Intersecting identities and substance use problems: sexual orientation, gender, race, and lifetime substance use problems. J Stud Alcohol Drugs. 2014;75:179–88. doi:10.15288/jsad.2014.75.179.
   PubMed Web of Science ®Google Scholar
• Novak P, Feder KA, Ali MM, Chen J. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: evidence from a national survey. J Subst Abuse Treat. 2019;98:47–52. doi:10.1016/j.jsat.2018.12.006.
   PubMed Web of Science ®Google Scholar
• Green CA. Gender and use of substance abuse treatment services. Alcohol Res Health. 2006;29:55–62.
   PubMedGoogle Scholar
• Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 1990;322:1202–6. doi:10.1056/NEJM199004263221706.
   PubMed Web of Science ®Google Scholar
• Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, Diop H, Bharel M, Krans EE, Selk S, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3:e205734. doi:10.1001/jamanetworkopen.2020.5734.
   PubMed Web of Science ®Google Scholar
• Williams AR, Johnson KA, Thomas CP, Reif S, Socias ME, Henry BF, Neighbors C, Gordon AJ, Horgan C, Nosyk B, et al. Commentary article: opioid use disorder cascade of care framework design: a roadmap. Subst Abus. 2022;43:1207–14.
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45:1–10. doi:10.1080/00952990.2018.1546862.
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, et al. Developing an opioid use disorder treatment cascade: a review of quality measures. J Subst Abuse Treat. 2018;91:57–68.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Linking people with opioid use disorder to medication treatment: a technical package of Policy, programs, and practices. National Center For Injury Prevention And Control, Centers For Disease Control And Prevention, Department Of Health And Human Services. 2022.
   Google Scholar
• Victor G, Kheibari A, Staton M, Oser C. Appalachian women’s use of substance abuse treatment: examining the behavioral model for vulnerable populations. J Soc Work Pract Addict. 2018;18:192–213. doi:10.1080/1533256X.2018.1450264.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health (NSDUH). 2021. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health (NSDUH): population data. https://www.datafiles.samhsa.gov/dataset/national-survey-drug-use-and-health-2019-nsduh-2019-ds0001.
   Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: a broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110:244–50. doi:10.2105/AJPH.2019.305412.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Key substance use and mental Health indicators in the United States: results from the 2019 national survey on drug use and Health. Center For Behavioral Health Statistics And Quality, Substance Abuse And Mental Health Services Administration. 2020.
   Google Scholar
• Sjolander A, Vansteelandt S. Frequentist versus bayesian approaches to multiple testing. Eur J Epidemiol. 2019;34:809–21. doi:10.1007/s10654-019-00517-2.
   PubMed Web of Science ®Google Scholar
• Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, Buchanan AL, Coderre T, Boss R, Rich JD, et al. Defining a recovery-oriented cascade of care for opioid use disorder: a community-driven, statewide cross-sectional assessment. PLoS Med. 2019;16:e1002963.
   PubMed Web of Science ®Google Scholar
• Walley AY, Lodi S, Li Y, Bernson D, Babakhanlou-Chase H, Land T, Larochelle MR. Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis. Addiction. 2020;115:1496–508. doi:10.1111/add.14964.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3:e1920622. doi:10.1001/jamanetworkopen.2019.20622.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Buntin MB, Martin PR, Scott TA, Dupont W, Richards M, Cooper, WO. Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Subst Abuse. 2019;40:356–62. doi:10.1080/08897077.2018.1488336.
   PubMed Web of Science ®Google Scholar
• Hollander MAG, Chang CH, Douaihy AB, Hulsey E, Donohue JM. Racial inequity in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use. Drug Alcohol Depend. 2021;227:108927. doi:10.1016/j.drugalcdep.2021.108927.
   PubMed Web of Science ®Google Scholar
• Frank D. “I was not sick and I Didn’t need to recover”: Methadone Maintenance Treatment (MMT) as a refuge from criminalization. Subst Use Misuse. 2018;53:311–22. doi:10.1080/10826084.2017.1310247.
   PubMed Web of Science ®Google Scholar
• Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L, Frank D, Brothers S. The methadone manifesto: treatment experiences and Policy recommendations from methadone patient activists. Am J Public Health. 2022;112:S117–S22. doi:10.2105/AJPH.2021.306665.
   PubMed Web of Science ®Google Scholar
• Lopez AM, Thomann M, Dhatt Z, Ferrera J, Al-Nassir M, Ambrose M, Sullivan S. Understanding racial inequities in the implementation of harm reduction initiatives. Am J Public Health. 2022;112:S173–S81. doi:10.2105/AJPH.2022.306767.
   PubMed Web of Science ®Google Scholar
• Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerdá M. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022;3:3. doi:10.1016/j.dadr.2022.100052.
   Google Scholar
• Kaufman JS, Cooper RS. Commentary: considerations for use of racial/ethnic classification in etiologic research. Am J Epidemiol. 2001;154:291–8. doi:10.1093/aje/154.4.291.
   PubMed Web of Science ®Google Scholar
• VanderWeele TJ, Robinson WR. On the causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology. 2014;25:473–84. doi:10.1097/EDE.0000000000000105.
   PubMed Web of Science ®Google Scholar